In November 2015, the CALYM Carnot Institute held a 2-d workshop to discuss the current and future development of immunomodulatory antibodies for the treatment of lymphoma. Highlights from the workshop are presented in this article.
- programmed cell death 1 ligand 1
- programmed cell death 1 receptor
ASJC Scopus subject areas
- Immunology and Allergy